|
|
|
|
LEADER |
02079nmm a2200457 u 4500 |
001 |
EB001902371 |
003 |
EBX01000000000000001065280 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
201006 ||| eng |
100 |
1 |
|
|a Shankar-Hari, Manu
|
245 |
0 |
0 |
|a Convalescent plasma therapy as a treatment for COVID-19
|h Elektronische Ressource
|c Manu Shankar-Hari
|
260 |
|
|
|a London
|b Henry Stewart Talks
|c 2020, 2020
|
300 |
|
|
|a 1 streaming audio file (15 min.))
|
505 |
0 |
|
|a Contents: What is convalescent plasma therapy -- Does this treatment confer long-lasting immunity? -- Mechanism of action of therapeutic antibodies -- Counterindications with plasma transfusions -- The need for lengthy clinical trials -- Preliminary assessment of convalescent plasma therapy in a clinical trial -- When might this treatment be approved, and how fast can it be delivered?
|
653 |
|
|
|a Coronavirus infections / Treatment
|
653 |
|
|
|a Antibodies, Viral / therapeutic use
|
653 |
|
|
|a COVID-19
|
653 |
|
|
|a Viral antibodies
|
653 |
|
|
|a severe acute respiratory syndrome coronavirus 2
|
653 |
|
|
|a Pneumonia, Viral / prevention & control
|
653 |
|
|
|a Blood plasma
|
653 |
|
|
|a Clinical trials
|
653 |
|
|
|a Blood Donors
|
653 |
|
|
|a Pneumonia, Viral / therapy
|
653 |
|
|
|a Clinical Trials as Topic
|
653 |
|
|
|a Coronavirus infections / therapy
|
653 |
|
|
|a Coronavirus infections / prevention & control
|
653 |
|
|
|a Betacoronavirus / immunology
|
653 |
|
|
|a COVID-19 (Disease) / Research
|
653 |
|
|
|a Antibodies, Viral / administration & dosage
|
653 |
|
|
|a Coronavirus infections / immunology
|
653 |
|
|
|a Antibodies, Viral / blood
|
653 |
|
|
|a Immunization, Passive
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b HST
|a Henry Stewart Talks
|
490 |
0 |
|
|a Research and clinical interviews
|
500 |
|
|
|a Audio interview. - Title from title frames. - Mode of access: World Wide Web
|
856 |
4 |
0 |
|u https://hstalks.com/bs/4323
|x Verlag
|z Streaming video file
|
856 |
4 |
2 |
|u https://hstalks.com/bs/p/1060
|3 Series
|
082 |
0 |
|
|a 570
|